Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for acute hysteria symptoms in the emergency department
IRCT20220516054869N4Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Dissociative neurological symptom disorder (DNSD) comparing Midazolam with Placebo (2 arms). Primary endpoints: Presence of hysteria symptoms and Drug side effects. Started Dec 2022; status: completed.
02
Drugs
midazolam
03
Conditions
Dissociative neurological symptom disorder (DNSD)
Beyond the preview
Go deeper on IRCT20220516054869N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220516054869N4.